W
BMGL

WealthCollab’s Basel Medical BMGL Stock Holding History

WealthCollab’s Portfolio BMGL Stock Details BMGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-79
Closed -$1.74K – 1111
2025
Q3 		$1.74K Buy
+79
New +$1.98K ﹤0.01% 857

Other funds holding BMGL

GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return

WealthCollab's BMGL Position: Q4 2025 in Review

WealthCollab sold out of Basel Medical (BMGL) in Q4 2025, closing a stake of 79 shares — an estimated $1.74K sold.

WealthCollab first reported a position in BMGL in Q3 2025 and held it in 1 quarter. The position peaked at $1.74K in Q3 2025. 9 funds tracked by Wall St. Rank hold BMGL as of Q4 2025.

  • WealthCollab reported no remaining Basel Medical position as of Q4 2025 after selling out during the quarter.
  • WealthCollab sold 79 Basel Medical shares in Q4 2025, an estimated $1.74K.
  • WealthCollab first reported a position in Basel Medical in Q3 2025 and held it in 1 quarter.
  • WealthCollab's Basel Medical position peaked at $1.74K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Basel Medical as of Q4 2025.

Based on WealthCollab's 13F filing for Q4 2025, filed 27 Jan 2026.